title: Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
authors.affiliation: Division of Haematology, Ospedale S. Martino, Genova, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Carella
authors.forename: E
authors.initials: E
authors.lastname: Pungolino
authors.forename: G
authors.initials: G
authors.lastname: Piatti
authors.forename: D
authors.initials: D
authors.lastname: Giordano
authors.forename: R
authors.initials: R
authors.lastname: Cerri
authors.forename: M
authors.initials: M
authors.lastname: Risso
authors.forename: S
authors.initials: S
authors.lastname: Nati
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D003561:Cytarabine; D005047:Etoposide; D015255:Idarubicin